The global prevalence and prevention progress of lung cancer

doi:10.19401/j.cnki.1007-3639.2020.10.001

China Oncology ›› 2020, Vol. 30 ›› Issue (10): 721-725.doi: 10.19401/j.cnki.1007-3639.2020.10.001

• Specialists’ Commentary and Article • Previous Articles Next Articles

The global prevalence and prevention progress of lung cancer

XIAO Jialong, ZHENG Ying

Department of Cancer Prevention Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China

Online:2020-10-30 Published:2020-11-11
Contact: ZHENG Ying E-mail: zhengying@fudan.edu.cn

Abstract

Abstract: “World Cancer Report 2020” was published by the International Agency for Research on Cancer (IARC) with the context of China. This article briefly introduced the global and Chinese lung cancer prevalence and survival, and the related research progress on the main risk factors of lung cancer, including genetic susceptibility, major carcinogens, air pollution, past lung diseases, as well as screening and other prevention.

Key words: Lung cancer, Incidence, Risk factor, Screening

XIAO Jialong, ZHENG Ying. The global prevalence and prevention progress of lung cancer[J]. China Oncology, 2020, 30(10): 721-725.

[1]	WANG Zezhou , ZHANG Yang , MO Miao , YUAN Jing , ZHOU Changming , SHEN Jie , FENG Xiaoshuang , WU Haoxuan , LI Hang , YE Ting , HU Hong , CHEN Haiquan , ZHENG Ying . Distribution of metastatic sites and survival analysis of patients with non-metastatic lung cancer at initial diagnosis based on hospital registration [J]. China Oncology, 2021, 31(9): 775-782.
[2]	LU Li, LU Renquan, SUN Jiajun, LU Ning, GUO Lin. The application of serum N-MID in auxiliary diagnosis and therapeutic effect monitoring of bone metastasis in patients with primary lung cancer [J]. China Oncology, 2021, 31(9): 838-844.
[3]	ZHU Yihui, LI Ting, HU Xichun. Clinical research progress and prospect of trastuzumab deruxtecan [J]. China Oncology, 2021, 31(8): 754-761.
[4]	LI Haizhou , ZHANG Yanwei , XU Yingjie , YANG Men , ZHANG Lei , HAN Jingjun . miR-933 inhibits proliferation, migration and invasion of lung cancer cell lines by regulation of KLF6 gene [J]. China Oncology, 2021, 31(7): 581-588.
[5]	YANG Jia , LIU Shuyuan , WANG Yingying , LI Yingfu , MA Qianli , LI Yu , WANG Yongrong , LI Chuanyin , TAN Fang . The association of polymorphisms in TNF-α gene with non-small cell lung cancer in Han population of Yunnan Province [J]. China Oncology, 2021, 31(7): 616-628.
[6]	XIE Mengqing, CHU Xiangling, ZHOU Juan, SU Chunxia. The advances in immunotherapy biomarkers of small cell lung cancer [J]. China Oncology, 2021, 31(7): 635-639.
[7]	QIAO Tingting , GE Shujing , LUO Yuan , LU Chengrong , DUAN Lianning . Mechanism of inhibition of epithelial-to-mesenchymal transition by phosphorylated H2AX in lung cancer cells [J]. China Oncology, 2021, 31(4): 277-284.
[8]	LU Ming, HONG Yuming, ZHENG Chaohui, CHEN Xiaofang, LIANG Zhenyuan. Factors influencing postoperative hypercoagulability of free flap reconstruction for head and neck tumor [J]. China Oncology, 2021, 31(4): 317-322.
[9]	MU Lina , SU Jia , YU Shunzhang , NIU Rungui , HAN Xiaoyou , LIU Li , SHI Jianping , ZHANG Zuofeng . The control of lung cancer relating to quitting active smoking and secondary smoking: a case-control study of lung cancer in Taiyuan [J]. China Oncology, 2021, 31(4): 335-343.
[10]	YI Weili , ZHAO Wencheng , HUANG Dongning , QIN Li , WU Xintian , ZHOU Fei , WU Fengying . Analysis of immune-related adverse events and its correlation with efficacy of anti-PD-1 monotherapy in advanced non-small cell lung cancer [J]. China Oncology, 2021, 31(3): 203-211.
[11]	ZHAO Yuanyuan , ZHOU Jianying , FAN Yun , WANG Jialei , HUANG Dingzhi , LI Junling , SHI Meiqi , LIU Jiwei , YAO Yu , WU Lin , YAO Wenxiu , ZHANG Li . Advances in the treatment of BRAF V600-mutant non-small cell lung cancer [J]. China Oncology, 2021, 31(12): 1145-1152.
[12]	WU Ran , WANG Guizhen , CHENG Xin , ZHOU Guangbiao . The effects of copper ion on cell proliferation and the clinical significance of copper ion in lung cancer [J]. China Oncology, 2021, 31(11): 1072-1080.
[13]	SHEN Yujia , FU Xiaolong . Research progress of immune contexture in tumorigenesis, progression and prognostic relevance of non-small cell lung cancer [J]. China Oncology, 2021, 31(11): 1115-1125.
[14]	WU Chunxiao , GU Kai , PANG Yi , BAO Pingping , WANG Chunfang , SHI Liang , GONG Yangming , XIANG Yongmei , DOU Jianming , SHI Yan , FU Chen . Analysis of the current status of cancer incidence and mortality in Shanghai, 2016 and trends of 2002-2016 [J]. China Oncology, 2021, 31(10): 879-891.
[15]	LIU Qian , QIAO Meng , MAO Shiqi , YANG Shuo , LIU Yiwei , ZHAO Chao , LI Xuefei , REN Shengxiang , ZHOU Caicun . Impact of metastatic organ on prognosis in extensive-stage small cell lung cancer [J]. China Oncology, 2021, 31(1): 45-51.

The global prevalence and prevention progress of lung cancer

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments